Ravi Gupta, MD, MS

Assistant Professor of General Internal Medicine, Johns Hopkins School of Medicine & Bloomberg School of Public Health

Ravi Gupta, MD, MS is a board-certified internal medicine physician and Assistant Professor of General Internal Medicine at the Johns Hopkins School of Medicine and at the Bloomberg School of Public Health. His work has focused on strengthening FDA regulation and improving prescription drug policy, with an emphasis on intellectual property, anti-competitive behaviors, and ensuring affordability and access to safe and effective therapies in the U.S. and globally. He also researches access to treatment of opioid use disorder and the social, economic, and commercial determinants that enabled the opioid epidemic, as well as the areas of private provision of public services, including Medicare Advantage, Medicaid managed care, and value-based and alternative payment models. His work has been published widely, including in JAMA, New England Journal of Medicine, British Medical Journal, Health Affairs, Boston Review, STAT News, and the New York Times. Ravi previously worked for two years in development economics with the MIT Jameel Poverty Action Lab in Bihar, India, where with Pratham, a leading education NGO, he led randomized control trial evaluations of education and health programs. He has also worked with the Center for Medicare and Medicaid Innovation and the Maryland State Health Department. Dr. Gupta graduated from the Yale School of Medicine and completed his residency in Internal Medicine in the Johns Hopkins Hospital Osler Medical Training Program within the Urban Health track. He is also currently a member of the FDA Task Force for Doctors for America and Board Member of Universities Allied for Essential Medicines.